Share Name Share Symbol Market Type Share ISIN Share Description
Versarien LSE:VRS London Ordinary Share GB00B8YZTJ80 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +2.75p +12.94% 24.00p 23.50p 24.50p 24.75p 22.375p 22.375p 5,639,426 16:28:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Industrial Engineering 5.9 -2.2 -1.9 - 35.39

Versarien (VRS) Latest News (3)

More Versarien News
Versarien Takeover Rumours

Versarien (VRS) Share Charts

1 Year Versarien Chart

1 Year Versarien Chart

1 Month Versarien Chart

1 Month Versarien Chart

Intraday Versarien Chart

Intraday Versarien Chart

Versarien (VRS) Discussions and Chat

Versarien (VRS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
17:05:5523.0055,55512,777.65OK
16:43:4823.0042,6089,799.84OK
16:30:3324.5017,5304,294.85O
16:29:1124.0710,4122,506.17O
16:29:0224.9016,0003,984.00O
View all Versarien trades in real-time

Versarien (VRS) Top Chat Posts

DateSubject
17/11/2017
08:20
Versarien Daily Update: Versarien is listed in the Industrial Engineering sector of the London Stock Exchange with ticker VRS. The last closing price for Versarien was 21.25p.
Versarien has a 4 week average price of 13.50p and a 12 week average price of 12.25p.
The 1 year high share price is 28p while the 1 year low share price is currently 9.25p.
There are currently 147,475,409 shares in issue and the average daily traded volume is 2,292,546 shares. The market capitalisation of Versarien is £35,394,098.16.
11/11/2017
11:30
dr andrewd: The next thing I have been considering was what other companies are out there that could be like VRS and how have things developed for them. One obvious area to look at are companies that make carbon fibre who have developed from nothing to multi billion dollar companies over 20-30 years selling carbon fibre and the like to the aerospace industry. They are selling into the same markets as VRS will be targeting for Nanene such as aerospace, but graphene will have far more potential markets as well. Four of the companies are: - Cytex (now part of the Solway group) annual sales 2014 of approx $1bn and 20% margin for aerospace before Solway took them over htTps://www.solvay.com/en/binaries/Cytec%20Q414%20Prez-267980.pdf - Hexcel $5.4bn mcap, share price increased approx 10 fold in last 10 years, revenue ~$2bn htTp://phx.corporate-ir.net/phoenix.zhtml?c=75598&p=irol-fundTrading htTp://phx.corporate-ir.net/phoenix.zhtml?c=75598&p=irol-fundSnapshot - Toho Tenax , part of the Teijin group with composites sales around £1bn htTps://www.teijin.com/ir/finance/segment/ - Toray group, who's composites I am very familiar with, has a £13bn mcap with sales of carbon fibre around £1bn per year, and on a % operating income basis, £2.6bn value could be attributed to sales of carbon fibre. htTp://www.toray.com/ir/achievement/ach_007.html So there are many multi billion £ companies selling raw and processed materials to make CFRP. The question then is whether VRS can sit alongside these companies supplying Nanene to improve many of the same products that the OEMs make today from the raw CFRP material. The CFRP companies have grown significantly over recent years as aerospace has adopted their materials whilst they have been around supplying Carbon fibre for 25-35 years. As I see it, these companies have done much of the leg work to create the market, graphene and hopefully Nanene will just build on that work over a shorter timeframe to create a better CFRP. Perhaps long term there may be half a dozen graphene companies similar to the half a dozen multi billion pound Carbon Fibre companies and hopefully VRS will be one of them. Also whilst the actual potential for sales into the CFRP market is uncertain, there are other huge markets such as printing, batteries etc etc. I certainly can't be sure that VRS will get to that size, but it could be possible. If you look more closely at some of the above companies they are into a range of technologies, for example Toray £13bn mcap makes all sorts of fibres of different types, similar to VRS will hopefully make Nanene and graphene ink for a huge range of applications. The potential assuming graphene delivers could be huge, but I am sure there will be many hurdles along the way which may prevent it happening. AIMO
26/9/2017
20:12
luckyorange: Now now phoenix, I think that he is the only one who can provide clarity on this lol. He may have single handedly stopped the dive in the VRS share price although 14p may always have been the stopping point so there is no way of knowing. Unfortunately I think that he has made a mistake in bailing as he so often pointed out regarding LO, however it is not for us to judge what is right or wrong , we will know in the near future what was the pragmatic thing to do. There seem to be many with a similar holding to warwick that are investors rather than traders. Sadly warwick seems to be propping up the share price on the other one for other traders to exit, but he has his goggles on!
22/9/2017
18:30
superg1: So there is quick comparison for you. Directa with an M/C of £27.7 mill £650k of revenue with a warning that is going to significantly drop and losses of £5.5 mill. VRS with around £8.5 mill revenue to come with growing sales market cap £19.4 mill. A completely bonkers market purely driven by how tight share are. Worse still Directa was over £50 mill just months back and the share price collapsed. \ However up steps William Game of Cantor Fitzgerald pumping it in a note. The note had lies in it so I wondered what his motive may be to drive up the share price after the collapse. Then I spotted it. His bruvs fund holds near 10% of the shares. Nice One will and Hopefully the FCA are on the case. I have asked they check for trades by the fund to make sure they don't sell into that lying note. Here you go Cantor Fitzgerald has upgraded Directa Plus Plc (LON:DCTA), saying the graphene-products supplier is “profoundly221; undervalued at the current share price. That share price was 32p or so when the broker note was written; it is now 38p after Cantor’s argument that the stock is bafflingly mispriced. Baffingly mispriced ??? 740k and a warning of a significant drop to come.
13/9/2017
15:23
severnof9: My view of the AGM Allotment of 19 million additional shares The intention is to issue for cash if the need arises. Usually allot 10% of shares but Versarian have chosen to issue 15%. The rationale is that this is a very interesting time in the growth of the business and they require maximum flexibility to achieve on what is an outstanding opportunity. Previously the Co used to raise cash with a placing but this exposes the Co to uncertainty while the placing is concluded. The institutions take maximum advantage during this delay. However, on the last occasion they used Primary Bid Platform which did not please the city but allowed private investors a similar opportunity to the city to buy at a discount. They were massively oversubscribed and allotted more shares to take advantage of the interest and to benefit PI’s (the intention was 50% to institutions and 50 % to PI’s but due to PI interest they allotted 0.5 million additional shares. If they need to raise capital again they may go for a 100% PI placing through Primary Bid or similar platform. The draw-back is that limited notice is required i.e. issued on a Friday and completed over the weekend. PI’s need to have ready cash to take advantage of any such placing. There is no immediate intention to use this facility My view That is a risk to any future placing which may be under subscribed so I would expect some Institutional Investment involvement in future to at least part underwrite any future placing. Buyback of up to 13 million shares Again this is for maximum flexibility. . No present intention to utilise this facility but could aid in flattening the volatility of a share price. NR referred to the recent LO selling following the Henderson team joining LO. He felt the share price has held up well in view of the numbers being sold but buy buck gives potential tool to exert some control where excessive selling isn’t justified and an advantage could be achieved through a buyback. NR happy when people sell as he does not want to benefit those who aren’t firm/committed shareholders. Clearly he genuinely believes the prospects of the Co are very bright. However, like all of us he is sad when the price is low and happier when the price is high. This is still a speculative proposition but NR is working hard to secure a development or commercial order and his job is to prioritise this from all of the unsolicited approaches they receive. Currently there are about 120 multinationals that the Co has had enquiries from. His priority is to get the product out there and currently there is a conflict between providing free/ subsidised a samples and charging a commercial rate for the product... Once a multinational expresses interest they absorb a lot of management time with queries etc. At that point to test commitment NR asks for a £100K commitment for exclusivity. The Multinationals move very slowly and only move fast once they have lost ground to their competitors. By securing that first commercial agreement the traction for further commercialisation will follow by competitors following suit. The priority on commercial contracts is Nanene and then Ink   Nanene Name is very well received to differentiate from competitors and NR feels VRS was lucky to get the name ISO & Nanene Too early to apply for ISO certification as process is not understood. NR clear that Nanene will qualify but not the other products Nanene production Currently 100 g per day based on a 2 shift basis. Could increase x 10 for £ 150K capital outlay and limited employee costs as only semi-skilled work to produce it. 1Kg would equate to 1000 litre bottle. Product process is Not patented. Risk in patenting is that know how is public and large OEM simply copies without IP rights and runs the risk of patent suits. Approach of VRS is to keep it black box to avoid IP battles. NR believes VRS are the largest manufacturer and commercial seller of graphene product in the world. Could sell at £2000 per gram at £1998 profit but as indicated above a commercial decision is taken about pricing to get the product out there to secure that first big order. Can scale up in 8 weeks. Machine to do so is commercially available and it is simply a question of best cash utilisation as to when this will occur.In my view NR considers that commercial viability tipping point is fast approaching. Nanene Commercialisation 4 stages 1) Enquiry 2) NDA 3) Collaboration/development contract 4) Commercial Order. NR believes we are a long way into this process. When pressed no timetable was forthcoming as the timing is totally within the control of others. Licensing Nanene production NR would not be drawn but my view is that discussions are in play either internally in the Co or with an interested party. I suspect it is the latter NGI Can’t make graphene in quantity and buy in from VRS California NR off to west coast tomorrow. Through work with Manchester, NGI, Innovate & Cambridge received considerable unsolicited approaches leading to NR spending 10 days in California meeting the likes of Tesla, Microsoft Apple Google all at chief officer level Cheltenham site Moving Cu Foam to Princes Risborough to free up space. My view to enable VRS to produce Nanene enhanced carbon fibre components for retail/sale. NR wants to get away from simply producing Nanene as a commodity and exert greater control by producing graphene enhanced components. VRS could be a world first in production line of graphene enhanced carbon fibre products with ISO certification. They have already produced a sled for the Olympic team in collaboration with Sheffield University with a view to having their product out there and independently tested/verified. My guess would be light weighting for aerospace parts that are not integral to the airframe example seats trolleys etc. Alternatively Grant Sinclair the production engineer was at the AGM at the invite of NR who believes collaboration with a product designer would benefit both. hxxp://www.grantsinclair.com/en/all-products.html Ink Products are available for printed graphene RFIDs and circuits. Been in discussion for 3 years re RFIDs with major US internet retailer but slow to progress given this is a disruptive technology Cu Foam Selling through Mouser with regular orders but not a current priority for VRS. VRS have learned that disruptive technology is not always welcomed as this entails considerable work to redesign by incumbents. Are however working with large manufacturer of internet infrastructure Conclusion I liked NR. He has a personal interest in seeing this succeed and I believe he will be successful. He is down to earth, genuinely appreciative of PI's and convinced he will succeed given the opportunities arising. he has the foresight to see the prospects for the future and the tenacity and commitment to succeed. I was reassured my investment is in good hands
06/9/2017
10:16
astralvision: phoenixs It's just me, but I have no interest in discussing another share on here. But I'm very happy to discuss VRS valuations. I did say yesterday as well that if graphene showed real financial progress, the market would or should award the graphene bit a high valuation. let's get this bit out the way first, I'm happy to buy more VRS on a rising share price and substantiated progress, I prefer to buy into a rising trend, so , no, I'm not trying to knock the share price down to buy lower. In any case, anything I do would be swamped by other PI's and funds, I ain't got that much spare! Onto valuations. VRS has the 'mature' businesses of carbide and AAC. Their worth is low, you only have to see what VRS paid for them to get an idea of their worth. I accept that VRS may have got them for a good price, and that they may help other aspects of the business and may help de-risk the graphene side. But the market cap of VRS will, imo, essentially derive from the Graphene businesses, where NR spends 90% of his time on. They are, as is to be expected at this stage, loss making. I would not class them as 'growth companies' yet, as growth, to me, implies at least rising revenues and VRS graphene is right at the early stage of revenue recognition. They may well become growth companies in time. The current VRS valuation of around £18m mainly hinges on 'hope value' for the graphene businesses. Nothing at all wrong in that, but that is where VRS are at. Progress, based on what NR said earlier in the year, is looking slower than NR anticipated. Nothing unusual there. So that's may take. I hope and trust that nothing in the above is too controversial and I don't get hung out to dry for taking a view that is slightly different to others.
06/8/2017
19:03
superg1: No JH as NDAs are not material on share price moves and therefore don't trigger an RNS. While you and I know if they put out a list of the multi £billion companies aims talking to them via news then it would very likely move the share price NDAs as said by the CEO are worthless. They become worth something when NDAs move to material MOUs JVs and the like. As the CEO said he could put out news every week about new collaborations but what is the point in that. I do note some do that but then some of those also lie in other news. They like hype. I did chuckle at one recently that compared their gains saying it was X amount better than current commercially available products. So if someone can show me a list what graphene related products are produced in bulk for worldwide sales for any product then I'd like to know. So no the Cambridge lot are not barred in any way the info is not material in nomad or company terms. Some do like to name them all though in news but that is up to them. It does help some that have no viable business in the short term but they will be found out in the end. At Cambridge we were also told (as I have said before) that Carbide had a new defence sales the first order of which had been paid for. Then another product for Aerospace where first supplies are expected Sept 17. I did discuss some of those and it was said in at least one case due to the underlying circs of how it came about (being vague there) that the company thought it should be in an RNS but the Nomad said no. It's a point I raise. There is no way the Nomad would want VRS telling PIs what lies behind that. If that were known and was slipped onto a BB then I'm sure the Nomad would rapidly change their mind and an RNS would appear. They like it both ways. One that they decide its not material and no rns but also that no one should be told even though they deem it not material. Why, because in some cases of lies underneath the share price could fly and then you have the same issue as an NDA if things don't fully materialise. So the it will be officially known who VRS are talking to is if one or more of them turns into something greater than a NDA, at which point probably is something to get excited about. I think nomads are very bad news for Aim companies and that rule should be abolished. After all they are wholly incompetent in identifying frauds. Th fact a nomad is there makes some think news must therefore be correct. Without names I think PIs would do a lot more of their own research and may not get sucked in so easily. As the MM said to me on investor day when I said 90% of nomads are bent. He corrected me saying 100% and he said so with a very stern look on his face. I haven't been tracking or invested in a share yet where I think the nomad is straight. Think of it this way nothing can get announced without going through the nomad first. So if a big name does end up as a deal the Nomad will know first. If you think inside info rules stops them and mates you'd be mistaken. I say that with great confidence having direct live experience of what they do at times.
02/8/2017
16:31
ridicule: John Henry I was the 108 seller at 10.10 today. I still have a substantial holding, but very few on here ever mention the lost 'opportunity cost' of trapped or dead money when a share languishes. I have mentioned the poor sales performance of VRS on this site several times over recent months; this has effectively stopped all the money invested here from working to create value over the period in question. I exited with a 16.83% profit on that holding this morning. This was achieved in less than 10 months. I have put the £18k to work elsewhere for a time where it can better earn its keep and possibly offset the dead money that I still have here because of the continued poor performance of the VRS share price due to lack of action. This is not trading Superg, its active investing. I still hold out hope for VRS which is why I still have a significant holding, Neill has not delivered sufficiently to stop me reducing at this stage however. As I see it, I can get back in in around 30 secs using 3 or 4 mouse clicks. I suspect the first signs of business breakthrough here will not be instantly transformational for the share price and I may be able to add at a lower price than today if matters remain as quiet here as they have over the last 9 months.
02/6/2017
16:38
rogerbridge: Yes SG, Epson in particular caught my eye for the ink side. Samsung and others spent a great deal of money on one company and ended up in a blind alley. There are some global companies who would be in touch with the NGI and Nanene has been certified and ready to go. As I have said before, once bitten, twice shy a lot of CTO's have egg on their faces and there will be more than one very unhappy CFO. CTO's will not want to make the same mistake twice, it's too risky for their career, let alone the company that they work for. There will be NDA's and a lot of testing and proving to do, but VRS have the genuine article, Nanene or Inks. Why would any company want to go elsewhere? There have been too many short term investors here and it may be several months before the blue touch paper is lit up. But then, what a beautiful site as VRS share price goes balistic. Well that's what I hope for, we shall see.
16/5/2017
18:32
superg1: Rhe I was having a conversation about 'investors' on BBs earlier today. Many are not investors but just short term share price chasers. I'm quite happy to do that with some but then I call it trading with little long term interest in the company and rarely post. Equally I know some on here are long term investors and they have build up positions in excess of 250k shares and others over 500k shares. Now with those amount you can more or less be called a potential long term investor as if you tried to offload those on bad news you are not going to get a good price. Then if you had managed to cash in over time on the drift then on good news you may want them back but the same problem exists. So for me when I like something I buy and hold as it's pointless me trying to guess on news and whether stock will be available. Currently it's still over 100% from a few months back and over 40% up since the fund raise. I have thoughts of a much higher share price based on the research and the leads VRS have, so I'll be hanging on for that but have an open target as one good turn could create another. I've watched companies go to ridiculous levels due to be signed up with 1 company and watched one well known AIM soar on the back of a deal with someone VRS are in an NDA with. So if such circs come about then anyone trying to get 250k shares or 500k shares plus is going to struggle and be battling with others looking to land up. Clearly there is enough churn/supply at the moment probably down to profit taking at this time and it may continue for weeks. However if big news come when there is no supply or big news ends such a supply then the share price would take off. When you get good prospects on the back of such news funds come in and sit sucking up all the trader sells. We've all seen it before. That's the gamble, go in when the share price is low while others are fearful, or wait and chase the trend with more security. Someone used Samsung as an example over on III. So if they signed with Samsung or Apple (just using the big names) what then. Is it a case of waiting to see if Apple or Samsung throw in a big order or take a stake in the company. Just throwing the thoughts out there. As mentioned I watched the herd nutters wet their pants as they have heard company A is talking to their Aim company and the BBs go ramptastic. VRS is chatting to 50-100 companies in NDAs many of which are very large companies. They in the main have approached VRS. Who was that company adding something to coke (tomato extract) chatting to coke, claims of factory staff with shares in tears as they were all going to be rich. PXS or something like that. Posters can be absolutely barmy at times, I have many as just seriously problematic gambling addicts and others just plain bonkers. The venom that comes out when greed turns into despair is incredible. Plenty of chat about sorting sales. They are sorting sales and the team has expanded since I last mentioned them. The last thing they need to be doing is to be making a pretty website for PIs to look at. The website doesn't create sales, the product and team do.
23/11/2016
11:08
ridicule: SG and others. We must all be careful that our gleened knowledge of Graphene and the associated GNPs do not become so influencial that they cloud our observations on business developments in this market. The following is out in print in the public domain and no one from either Haydale or Huntsman have challenged it to my knowledge: "Ray Gibbs, chief executive of Haydale, is confident a deal will soon be signed which could potentially create a recurring revenue stream for the small cap. It could be a big prize as Huntsman is a major resin supplier to the tooling market. Gibbs believes Haydale will be asked to supply a master batch of graphine-enhanced resin. Huntsman will then be responsible for sales and marketing. We believe they want to focus on the automotive industry for the enhanced resin, but they won't tell us until a license deal is signed he says. Gibbs suggests the contract-assuming one is awarded-would involve Haydale buying resin from hHntsman, adding its magic, and then selling the enhanced resin back to the chemicals group. That implies Haydale would need to find a chunk of cash to act as working capital to fund the purchase of the raw material." There are no indications of the quantities involved or the quality/type of the graphene infusion process. Given SGs input it would not seem that it is 'top end', but these people are not stupid and I cannot accept some of the comments here suggesting or infering that they are. I think we should be focusing on why the VRS NOMAD is not achieving the same level of publicity for VRS and ensuring the market understands where VRS sit in relations to competitors such as Haydale. If this was made clear and was as positive as SG believes, the share price would start to move. I for one, as an investor in VRS and not Haydale, would like to see far more clarity on where VRS sit. I hope there will be some clarification in 6 days time when the latest results are declared. Having a competitor in this field, such as Haydale, with only 17.01 million shares in issue and a share price of 180 -185p, compared to VRS with 105.52 shares in issue and a share price of just 11.5p makes me nervous. Haydale have a much stronger investment engine to raise funding to compete via equity release than VRS by an order of nearly 16 to 1 . Given this, I need to know just how much of different market VRS are operating in.
Versarien share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20171117 21:33:45